Cerebras Systems revenue and financials
In the fiscal year ended December 2025, Cerebras Systems reported revenue of $509.99M (+75.71% year over year). Net income was $237.83M, a net margin of 46.6%.
Fiscal year ending in December. Sources and method on the page How we analyse stocks.
At a glance
- Revenue growth
- +75.71%
- 2025 vs 2024
- Net margin
- 46.6%
- 2024: -165.9%
How Cerebras Systems is changing
Calculated from the annual statements; each fiscal year is labelled with the year it ends.
Revenue grew 174.6% a year on average over the last 3 years
Compound annual growth rate: from $24.62M in 2022 to $509.99M in 2025.
Revenue has grown for 3 fiscal years in a row
Each fiscal year compared with the one before, up to 2025.
Operating margin rose from −726.4% to −28.6%
Operating income over revenue, 2022 → 2025: 697.8 percentage points.
Shares outstanding up 314.2% in 3 years
Average diluted shares, 2022 → 2025: with more shares, each one represents a smaller stake in the company (dilution).
Profitable in 1 of 4 fiscal years
Positive net income, fiscal years 2022–2025.
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total revenue | 510 | 290 | 78.7 | 24.6 |
| Cost of revenue | 311 | 168 | 52.4 | 21.7 |
| Gross profit | 199 | 123 | 26.4 | 2.9 |
| Selling, general and administrative | 102 | 65.9 | 20.2 | 26.3 |
| Research and development | 243 | 158 | 140 | 155 |
| Operating income | -146 | -101 | -134 | -179 |
| EBIT | -146 | -101 | -134 | -179 |
| EBITDA | -111 | -89.9 | -123 | -167 |
| Pre-tax income | 245 | -480 | -127 | -178 |
| Income tax | 7.1 | 1.9 | 0.1 | 0.2 |
| Net income | 238 | -482 | -127 | -178 |
| Net income to common shareholders | 87.9 | -485 | -127 | -178 |
| Basic EPS | 1.64 | -9.90 | -2.92 | -4.28 |
| Diluted EPS | 1.38 | -9.90 | -2.92 | -4.28 |
| Average shares (basic) | 53.6 | 49.0 | 43.6 | 41.5 |
| Average shares (diluted) | 172 | 49.0 | 43.6 | 41.5 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 | Q2 2024 | Q1 2024 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|
| Total revenue | 180 | 193 | 103 | 99.5 | 68.2 | 68.2 | 4.3 | 4.3 |
| Cost of revenue | 154 | 107 | 71.2 | 57.9 | 40.2 | 40.2 | 2.1 | 2.1 |
| Gross profit | 26.0 | 86.2 | 32.1 | 41.6 | 28.0 | 28.0 | 2.2 | 2.2 |
| Selling, general and administrative | 183 | 25.7 | 28.5 | 17.3 | 10.0 | 10.0 | 4.5 | 4.5 |
| Research and development | 320 | 75.5 | 60.8 | 52.8 | 38.9 | 38.9 | 38.1 | 38.1 |
| Operating income | -477 | -15.0 | -57.2 | -28.5 | -20.9 | -20.9 | -40.5 | -40.5 |
| EBIT | -477 | -15.0 | -57.2 | -28.5 | -20.9 | -20.9 | -40.5 | -40.5 |
| EBITDA | -453 | 3.1 | -51.8 | -24.6 | -18.8 | -18.8 | -37.7 | -37.7 |
| Interest expense | 19.7 | 18.9 | 0.0 | 0.0 | — | — | — | — |
| Pre-tax income | -450 | -12.5 | 311 | -22.2 | -33.1 | -33.1 | -38.9 | -38.9 |
| Income tax | 0.3 | 1.5 | 1.7 | 1.7 | 0.2 | 0.2 | 0.0 | 0.0 |
| Net income | -451 | -14.0 | 310 | -23.9 | -33.3 | -33.3 | -38.9 | -38.9 |
| Net income to common shareholders | -451 | -14.0 | 120 | -9.7 | -33.3 | -33.3 | -38.9 | -38.9 |
| Basic EPS | -2.98 | -0.22 | 2.28 | -0.19 | -0.71 | -0.71 | -0.91 | -0.91 |
| Diluted EPS | -2.98 | -0.22 | 1.91 | -0.19 | -0.71 | -0.71 | -0.91 | -0.91 |
| Average shares (basic) | 151 | 62.8 | 52.7 | 52.0 | 46.9 | 46.9 | 42.9 | 42.9 |
| Average shares (diluted) | 151 | 62.8 | 162 | 52.0 | 46.9 | 46.9 | 42.9 | 42.9 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total assets | 2,326 | 1,113 | 225 | 281 |
| Current assets | 1,544 | 1,030 | 212 | 253 |
| Cash and equivalents | 702 | 220 | 34.8 | 26.1 |
| Short-term investments | 407 | 117 | 118 | 199 |
| Receivables | 74.0 | 151 | 6.8 | 5.1 |
| Inventory | 63.6 | 174 | 49.1 | 19.5 |
| Net property, plant and equipment | 686 | 79.7 | 13.0 | 28.1 |
| Current liabilities | 720 | 1,178 | 54.6 | 21.8 |
| Accounts payable | 48.6 | 25.6 | 14.7 | 5.1 |
| Total debt | 262 | 40.7 | 0.6 | 1.3 |
| Total liabilities | 971 | 1,229 | 61.7 | 25.0 |
| Total equity (incl. minority) | 1,355 | -117 | 164 | 256 |
| Retained earnings | -905 | -1,143 | -662 | -534 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 | Q2 2024 | Q1 2024 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 11,628 | 4,948 | — | — | 623 | 623 | — | — |
| Current assets | 9,122 | 3,581 | — | — | 572 | 572 | — | — |
| Cash and equivalents | 6,742 | 1,716 | — | — | 90.9 | 90.9 | — | — |
| Short-term investments | 1,179 | 516 | — | — | 119 | 119 | — | — |
| Receivables | 171 | 103 | — | — | 5.8 | 5.8 | — | — |
| Inventory | 32.7 | 89.0 | — | — | 78.0 | 78.0 | — | — |
| Net property, plant and equipment | 1,515 | 926 | — | — | 48.4 | 48.4 | — | — |
| Current liabilities | 1,566 | 1,427 | — | — | 443 | 443 | — | — |
| Accounts payable | 88.3 | 50.3 | — | — | 13.4 | 13.4 | — | — |
| Long-term debt | 182 | 362 | — | — | — | — | — | — |
| Total debt | 1,487 | 1,362 | — | — | 28.0 | 28.0 | — | — |
| Total liabilities | 2,473 | 2,196 | — | — | 479 | 479 | — | — |
| Total equity (incl. minority) | 9,155 | 2,753 | — | -117 | 143 | 143 | — | 256 |
| Retained earnings | -1,370 | -919 | — | — | -728 | -728 | — | — |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Operating cash flow | -10.1 | 452 | -79.0 | -164 |
| Depreciation and amortization | 34.5 | 11.5 | 10.6 | 11.9 |
| Capital expenditure | -383 | -23.4 | -6.6 | -10.5 |
| Investing cash flow | -668 | -16.8 | 81.7 | 137 |
| Financing cash flow | 1,027 | 112 | 5.9 | 9.1 |
| Share repurchases | -24.3 | -0.1 | 0.0 | -3.9 |
| Effect of exchange rates | -0.5 | -0.3 | -0.1 | -0.3 |
| Net change in cash | 348 | 547 | 8.6 | -18.2 |
| Free cash flow | -393 | 429 | -85.6 | -175 |
| Levered free cash flow | -623 | 460 | -51.9 | — |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 | Q2 2024 | Q1 2024 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -59.8 | 12.3 | -68.9 | -54.9 | 156 | 156 | -35.1 | -35.1 |
| Depreciation and amortization | 24.4 | 18.2 | 5.4 | 3.9 | 2.1 | 2.1 | 2.8 | 2.8 |
| Capital expenditure | -417 | -132 | -86.9 | -98.2 | -5.9 | -5.9 | -0.2 | -0.2 |
| Investing cash flow | -1,073 | -237 | -30.6 | -56.7 | -4.9 | -4.9 | 27.7 | 27.7 |
| Financing cash flow | 5,815 | 2,038 | 3.6 | 1.6 | 8.6 | 8.6 | 1.2 | 1.2 |
| Share repurchases | -416 | -0.6 | 0.0 | 0.0 | — | — | — | — |
| Debt issued | 0.0 | 1,005 | 0.0 | 0.0 | — | — | — | — |
| Effect of exchange rates | -0.3 | 0.9 | 0.7 | 0.2 | -0.1 | -0.1 | 0.0 | 0.0 |
| Net change in cash | 4,682 | 1,815 | -95.1 | -110 | 160 | 160 | -6.1 | -6.1 |
| Free cash flow | -477 | -120 | -156 | -153 | 150 | 150 | -35.3 | -35.3 |
| Levered free cash flow | -175 | — | — | — | -0.7 | — | — | — |
Financial statements of similar companies
Companies in the group: same industry, similar size
